Acute respiratory distress syndrome (ARDS), a fatal critical disease, is induced by various
insults. ARDS represents a major global public health burden, and the management of …

Background Glucocorticoids are some of the most commonly used drugs for patients with
acute respiratory distress syndrome (ARDS). However, the curative effect and side effects of …

Acute lung injury/acute respiratory distress syndrome (ALI/ARDS), triggered by various
pathogenic factors inside and outside the lungs, leads to diffuse lung injury and can result in …

Acute respiratory distress syndrome (ARDS) is a unique entity marked by various etiologies
and heterogenous pathophysiologies. There remain concerns regarding the efficacy of …

Background Acute respiratory distress syndrome (ARDS) is a common and disabling
disease with high rates of mortality and morbidity. The role of steroids in treating ARDS …

The acute respiratory distress syndrome (ARDS) is a common and vexing problem faced by
critical care providers worldwide. Despite extensive investigation over the past 3 decades …

To date, the efficacy of glucocorticoid therapy to reduce mortality in patients with acute
respiratory distress syndrome (ARDS) has remained controversial among the studies …

Purpose To investigate the effect of prolonged glucocorticoid treatment for patients with
acute respiratory distress syndrome (ARDS). Methods We conducted two sets of intention-to …

Current literature addressing the pharmacological principles guiding glucocorticoid (GC)
administration in ARDS is scant. This paucity of information may have led to the …

Acute respiratory distress syndrome (ARDS) is frequently associated with sepsis. ARDS and
sepsis exhibit a common pathobiology, namely excessive inflammation. Corticosteroids are …